Skip to main content
Contact Us
Subscribe
E-Edition
65°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hepion Pharmaceuticals Inc
(NQ:
HEPA
)
0.6500
-0.0091 (-1.38%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hepion Pharmaceuticals Inc
< Previous
1
2
3
Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 25, 2024
Via
Benzinga
Why Deckers Outdoor Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
October 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 18, 2024
Via
Benzinga
HEPA Stock Earnings: Hepion Pharmaceuticals Reported Results for Q2 2024
August 13, 2024
Hepion Pharmaceuticals just reported results for the second quarter of 2024.
Via
InvestorPlace
Fatty-Liver Focused Hepion Pharmaceuticals Agrees To Merge With Israel-Based Parkinson's Disease Drug Developer
July 22, 2024
Hepion Pharmaceuticals announces merger with Pharma Two B Ltd., creating a combined company focused on Parkinson's disease treatment. The merger values Hepion at $58.5 million, and Pharma Two B plans...
Via
Benzinga
HEPA Stock Earnings: Hepion Pharmaceuticals Reported Results for Q1 2024
May 21, 2024
Hepion Pharmaceuticals just reported results for the first quarter of 2024.
Via
InvestorPlace
S&P 500 Rises Over 1%; Zions Bancorp Shares Gain After Q1 Earnings
April 22, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?
April 22, 2024
Updates on Hepion Pharmaceuticals' ASCEND-NASH Trial, now in wind-down phase. Explore insights into Phase 2b study progression and strategic alternatives.
Via
Benzinga
Why Vaxxinity Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 22, 2024
Via
Benzinga
Gold Falls Sharply; Matterport Shares Spike Higher
April 22, 2024
Via
Benzinga
Nike Layoffs 2024: What to Know About the Latest Nike Job Cuts
April 22, 2024
Nike layoffs are on the way as the athletic wear company is preparing to cut 740 jobs in two rounds at its global headquarters.
Via
InvestorPlace
Topics
Workforce
Exposures
Layoff
Dow Jumps Over 100 Points; Chicago Fed National Activity Rises In March
April 22, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Is Hepion Pharmaceuticals (HEPA) Stock Down 41% Today?
April 22, 2024
Hepion Pharmaceuticals stock is falling on Monday as investors in HEPA learn of the company winding down a Phase 2b clinical trial.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 22, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 22, 2024
It's time to start ofd the trading week with a look at the biggest pre-market stock movers traders need to watch on Monday morning!
Via
InvestorPlace
HEPA Stock Earnings: Hepion Pharmaceuticals Beats EPS for Q4 2023
April 16, 2024
HEPA stock results show that Hepion Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 13, 2023
Via
Benzinga
Over $18M Bet On Asana? Check Out These 3 Stocks Insiders Are Buying
September 21, 2023
Although U.S. stocks closed lower on Wednesday following Fed’s rate decision, there were a few notable insider trades.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
September 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
May 25, 2023
Via
Benzinga
Why Microvast Holdings Shares Are Trading Lower By Around 22%; Here Are 20 Stocks Moving Premarket
May 23, 2023
Gainers Applied UV, Inc. (NASDAQ: AUVI) shares rose 44.6% to $0.69 in pre-market trading after posting better-than-expected quarterly sales.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 23, 2023
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on Tuesday!
Via
InvestorPlace
Tesla, Zoom, Hepion, Pfizer, ZIM: Why These 5 Stocks Are Drawing Investor Attention Today
May 22, 2023
Via
Benzinga
Hepion Pharmaceuticals (NASDAQ: HEPA) Reports Promising Phase 2 Trial Results for NASH Treatment
May 22, 2023
Renocofilstat's Positive Outcomes Reinforce Antifibrotic Action Hepion Pharmaceuticals, a clinical stage biopharmaceutical company focusing on AI-assisted therapeutic drug development, recently
Via
Spotlight Growth
Topics
Death
Exposures
Death
12 Health Care Stocks Moving In Monday's Intraday Session
May 22, 2023
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.